Screener
Vaxcyte, Inc. PCVX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Total operating expenses | 345,850 | 180,793 |
| Loss from operations | (345,850) | (180,793) |
| Other income, net: | ||
| Interest income | 26,610 | 32,935 |
| Other income (expense) | (1,382) | 7,140 |
| Total other income, net | 25,228 | 40,075 |
| Net loss | $(320,622) | $(140,718) |
| Net loss per share, basic and diluted | $(2.30) | $(1.04) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s interest income?
- Vaxcyte, Inc. (PCVX) reported interest income of $26.61M in Q1 2026.
- How has Vaxcyte, Inc.'s interest income changed year-over-year?
- Vaxcyte, Inc.'s interest income decreased by 19.2% year-over-year, from $32.94M to $26.61M.
- What is the long-term trend for Vaxcyte, Inc.'s interest income?
- Over 4 years (2021 to 2025), Vaxcyte, Inc.'s interest income has grown at a 332.2% compound annual growth rate (CAGR), from $343K to $119.72M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Vaxcyte, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude